Daniella Licht
10Patents
6h-index
13Co-inventors
59Inventor score
Filing activity: Mar 27, 2000 → Sep 20, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7074392B1 | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections | Human Necessities | 35 | Expired |
| US7678366B2 | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | Human Necessities | 15 | Expired |
| US8178127B2 | Stable laquinimod preparations | Emerging Cross-Sectional Technologies | 14 | Active |
| US7989473B2 | Stable laquinimod preparations | Human Necessities | 14 | Active |
| US8080584B2 | Delayed release rasagiline citrate formulation | Chemistry; Metallurgy | 11 | Active |
| US8383645B2 | Stable laquinimod preparations | Human Necessities | 9 | Active |
| US8545885B2 | Stable laquinimod preparations | Emerging Cross-Sectional Technologies | 2 | Active |
| US9340307B2 | Stable laquinimod preparations | Emerging Cross-Sectional Technologies | 0 | Active |
| US8257688B2 | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | Human Necessities | 0 | Active |
| US8022104B2 | Formulations of ladostigil tartrate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.